AVP and autosomal dominant polycystic kidney disease: We found only one study investigating serum copeptin in pediatric ADPKD population in which no significant difference in plasma copeptin between patients (n = 53) and healthy controls (n = 53) was found (51), even though lower urine and plasma osmolality was noticed in patients.